(Q24246603)

26 October 2023

Anastasia Polycarpou

1

A

Polycarpou

1 reference

26 October 2023

Panagiotis Papanikolau

series ordinal

2

author given names

P

author last names

Papanikolaou

1 reference

26 October 2023

Despina Contopoulos Ioannidis

series ordinal

4

author given names

D G

author last names

Contopoulos-Ioannidis

1 reference

Cochrane Database of Systematic Reviews

26 October 2023

publication date

20 July 2005

0 references

published in

0 references

cites work

Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

The glutamatergic basis of human alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Comparative Evaluation of Treatments of Alcohol Withdrawal Syndromes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Diphenylhydantoin control of alcohol withdrawal seizures. Results of a controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Meta-analysis of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Reduction in early alcohol abstinence fits by administration of carbamazepine syrup instead of tablets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Ethanol and negative feedback regulation of mesolimbic dopamine release in rats

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Investigation of the abuse liability of buspirone in alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Clinical physiological study of the therapeutic effects of phenytoin in acute alcohol withdrawal and the asthenic-autonomic syndrome in patients with chronic alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Topiramate for the treatment of alcohol dependence: initiating abstinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Controlled trial of acupuncture for severe recidivist alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Alcohol and withdrawal: from animal research to clinical issues

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Emergency department treatment of alcohol withdrawal seizures with phenytoin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Glutamate-mediated transmission, alcohol, and alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Changes in EEG, blood levels, mood scales and performance scores during long term treatment with diazepam, phenobarbital or placebo in patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

The use of divalproex in alcohol relapse prevention: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Adjuvant drug treatment of alcoholism with acamprosate: between sectoral budgets and disease management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Retardiertes Carbamazepin in der Therapie des alkoholischen Prädelirs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Randomized clinical trial of atenolol in patients with alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Acupuncture in the treatment of alcohol withdrawal symptoms: a randomized, placebo‐controlled inpatient study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance--a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Divalproex in the Treatment of Alcohol Withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Autonomic reactivity to mental stressors after single administration of lorazepam in male alcoholics and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Post-detoxification drug treatment of anxiety and depression in alcohol addicts.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

A comparison of three approaches to alcohol-withdrawal states

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Alprazolam versus chlormethiazole in acute alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Is clonidine useful in the treatment of alcohol withdrawal?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

A placebo-controlled trial of buspirone in anxious inpatient alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Evaluation of chlormethiazole in treatment for alcohol withdrawal syndrome. Results of a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Experience with three drugs in ambulatory treatment of alcohol patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubl-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Delirium tremens: a double-blind comparison of diazepam and barbital treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Barbital and diazepam plasma levels during treatment of delirium tremens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Treatment of alcohol withdrawal symptoms in hospitalized patients. A randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Drug abuse: hedonic homeostatic dysregulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Controlled Trial of Chlormethiazole in Treatment of the Alcoholic Withdrawal Phase

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

An open study with acamprosate in Belgium and Luxemburg: results on sociodemographics, supportive treatment and outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Calcium-channel-blocking agent in the treatment of acute alcohol withdrawal--caroverine versus meprobamate in a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Prevention of Alcohol Withdrawal Seizures: The Roles of Diphenylhydantoin and Chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

The natural history of alcohol abuse: implications for definitions of alcohol use disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Finnish Experiences with Carbamazepine (Tegretol ®) in the Treatment of Acute Withdrawal Symptoms in Alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

A Comparison of the Efficacy and Tolerability of Clobazam and Chlordiazepoxide in the Treatment of Acute Withdrawal from Alcohol in Patients with Primary Alcoholism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Chlormethiazole and trifluoperazine in alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Tiapride in the prevention of relapse in recently detoxified alcoholics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Alcohol and the brain. Pharmacological insights for psychiatrists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Trends in the management of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Efficacy of acamprosate in the treatment of alcohol-dependent outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

Sodium valproate in the treatment of the alcohol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005064.PUB2

7 January 2021

10.1002/14651858.CD005064.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_daak2o35izhhzm5ybgktemxzou

0 references